---
schema_version: "secwatch.filing_event.v1"
accession: "0001425450-21-000148"
form_type: "8-K"
ticker: "KIDS"
cik: "0001425450"
company_name: "ORTHOPEDIATRICS CORP"
filed_at: "2021-11-04T23:59:59+00:00"
generated_at: "2026-06-28T12:48:58.408675+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# OrthoPediatrics director Berry retires, CEO Bailey joins board; compensation policy updated

## Summary
- Bernie Berry, III retired from board Nov 3, 2021 after 12 years; no disagreement. Granted 2,119 shares and accelerated vesting.
- CEO David R. Bailey appointed to fill vacancy, term until 2024; as employee director, no compensation.
- Board amended director compensation policy effective Jan 1, 2022: annual stock grant changed to $75,000 value, meeting fees to $18,750/quarter.
- Chairperson annual fees increased: Board, Comp, Gov committees to $5,000; Audit Committee chair to $10,000.

## SEC filing metadata
- accession: 0001425450-21-000148
- form_type: 8-K
- ticker: KIDS
- cik: 0001425450
- company_name: ORTHOPEDIATRICS CORP
- filed_at: 2021-11-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1425450/000142545021000148/0001425450-21-000148-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1425450/000142545021000148/kids-20211102.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001425450-21-000148
- JSON: https://secwatch.observer/filing/0001425450-21-000148.json
- Plain text: https://secwatch.observer/filing/0001425450-21-000148.txt

## Key facts
- Executive change
  Bernie Berry, III retired as Director at ORTHOPEDIATRICS CORP.
  - Action: retired
  - Role: Director
  source text: Effective November 3, 2021, Bernie Berry, III has retired from the Company's Board of Directors after twelve years of service.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1425450/000142545021000148/0001425450-21-000148-index.htm
- Executive change
  David R. Bailey was appointed as Director at ORTHOPEDIATRICS CORP.
  - Action: appointed
  - Role: Director
  source text: The Board has appointed David R. Bailey, the Company’s President and Chief Executive Officer, to fill the vacancy caused by Mr. Berry’s retirement to serve in the Class of Directors whose terms expire at the annual shareholder meeting in 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1425450/000142545021000148/0001425450-21-000148-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.